CA
NZ
UK
AU
IND
US
High-bandwidth memory (HBM) is among the most critical components in the evolving landscape of artificial intelligence (AI) applications. Micron Technology stands out as the sole US-based manufacturer of HBM3E memory, which is essential for powering the latest AI infrastructures. While the semiconductor industry grapples …
The rapid expansion of artificial intelligence (AI) technology has led to unprecedented investments in cloud infrastructure by major hyperscalers. Companies like Amazon Web Services (AWS), Microsoft Azure, and Google Cloud are each committing more than $100 billion annually to bolster their AI capabilities. This …
The recent partnership between NextEra Energy and Dominion Energy is a significant development in the utility sector, creating the largest utility partnership in a decade. This deal aims to combine the strengths of both companies, with NextEra providing its expertise in solar, battery storage, …
In a transformative move, S&P 500 companies are redirecting an estimated $400-500 billion annually from stock buybacks to artificial intelligence capital expenditures. This decision heralds the most significant corporate capital allocation change since the post-World War II industrial boom. The transition reflects a burgeoning …
CVS Health, a major player in the healthcare industry, is undergoing a significant transformation. The company has announced a three-part turnaround plan aimed at driving growth and improving profitability. This plan involves exiting unprofitable health insurance market segments, monetising its retail pharmacy locations, and …
Artificial intelligence is reshaping numerous industries, but its integration into cybersecurity has introduced complexities that confound traditional monitoring systems. At a recent CNBC tech conference, Datadog CEO Olivier Pomel outlined the duality of AI's role: while it enhances operational efficiencies, it also exponentially increases …
Eli Lilly and Company has once again signalled its ambition in the lucrative Alzheimer's market, announcing a licensing deal with AlzeCure Pharma valued at over $1 billion. This agreement grants Lilly global rights to AlzeCure's ACD856, a small molecule designed to modulate TrkA/BDNF signalling. …
The equity markets are witnessing a notable rotation, with the healthcare sector emerging as a surprising outperformer while technology stocks, particularly those in AI semiconductors, experience a sell-off. This shift is not merely a fleeting trend but a significant market structure signal indicative of …
IBM's $10 billion investment in quantum computing is a bold bet on an emerging technology that promises to revolutionize industries from pharmaceuticals to finance. The company's commitment is not just financial; it aims to lead the charge in developing practical quantum technologies. By 2029, …
A significant shift in artificial intelligence deployment is underway, with large enterprises increasingly favouring private cloud infrastructure over public cloud offerings. Recent disclosures from Broadcom reveal that its private cloud AI revenue experienced a remarkable surge of over 70% year-over-year, marking it as the …
Please wait processing your request...